Evidence map›Paper›PMID 41221463›Full record

ArticleMedicine and pharmacy reports2025

Adrenal incidentalomas: clinical, biological, imaging and therapeutic features.

Oumaima Magouri, Fatima Zahra Bentebbaa, Latifa Boutaybi, Nisrine Bouichrat, Siham Rouf, Hanane Latrech

Abstract read
In one paragraph

Article in Medicine and pharmacy reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. A longitudinal study of dual-energy X-ray absorptiometry status in menopausal women with adrenal tumors.Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Oumaima MagouriDepartment of Endocrinology-Diabetology and Nutrition, Mohammed VI University Hospital Center, Faculty of Medicine and Pharmacy, University of Mohammed 1st, Oujda, Morocco.
Fatima Zahra BentebbaaDepartment of Endocrinology-Diabetology and Nutrition, Mohammed VI University Hospital Center, Faculty of Medicine and Pharmacy, University of Mohammed 1st, Oujda, Morocco.
Latifa BoutaybiDepartment of Endocrinology-Diabetology and Nutrition, Mohammed VI University Hospital Center, Faculty of Medicine and Pharmacy, University of Mohammed 1st, Oujda, Morocco.
Nisrine BouichratDepartment of Endocrinology-Diabetology and Nutrition, Mohammed VI University Hospital Center, Faculty of Medicine and Pharmacy, University of Mohammed 1st, Oujda, Morocco.
Siham RoufDepartment of Endocrinology-Diabetology and Nutrition, Mohammed VI University Hospital Center, Faculty of Medicine and Pharmacy, University of Mohammed 1st, Oujda, Morocco.
Hanane LatrechDepartment of Endocrinology-Diabetology and Nutrition, Mohammed VI University Hospital Center, Faculty of Medicine and Pharmacy, University of Mohammed 1st, Oujda, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Adrenal incidentaloma is an adrenal mass discovered incidentally during an imaging examination that was not conducted to investigate an adrenal pathology. Its etiologies are varied, which determines the choice of different therapeutic options. The objective of our study is to describe the clinical, biological, etiological, and therapeutic aspects of adrenal incidentalomas in our series. Methods: This is a retrospective study including 55 patients who were managed for adrenal incidentalomas. Demographic characteristics, clinical evaluations, imaging features, and functional status were analyzed. Results: The mean age was 55.49 ± 13.53 years with a female predominance (65.4%). The circumstances of discovery were predominantly digestive (54.5%). Computed tomography (CT) was the most frequent imaging method used in the first detection of adrenal incindentalomas. These adrenal masses were unilateral in 72.8% of patients, and bilateral in 27.2% of cases. Their sizes ranged from 10 to 135 mm. In terms of secretory profile, the etiologies of adrenal incidentalomas were predominantly non-functional, followed by pheochromocytomas, and hypercortisolism, then primary hyperaldosteronism. Adrenalectomy was indicated for 23.6% of our patients. Conclusion: Our results are in agreement with those in the literature, showing that patients with an incidental adrenal mass need a multidisciplinary approach involving clinical and biological screening for endocrine hypersecretion, as well as radiological evaluation to ensure an effective etiological diagnosis and to establish a personalized and optimal therapeutic management plan.

Indexed as

adrenalectomyadrenal incidentalomascomputed tomographyhypercortisolismpheochromocytomaprimary hyperaldosteronism

Identifiers

PMID41221463
PMCPMC12600068

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.